Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Mise à jour : Il y a 4 ans
Référence : NCT00225277

Femme et Homme

Extrait

The purpose of this study was to determine the efficacy of pioglitazone, once daily (QD), compared to glimepiride on atherosclerotic disease measured by intravascular ultrasound.


Critère d'inclusion

  • Diabetes Mellitus


Liens